Brand-specific influenza vaccine effectiveness in the Nordic countries

First published 21/02/2025

Last updated 16/06/2025

EU PAS number:

EUPAS1000000481

Study

Finalised

Documents

Study protocol

Initial protocol

Brand-specific IVE in Nordic settings.pdf

English (846.37 KB - PDF)View document

Updated protocol

Brand-specific IVE in Nordic settings.pdf

First published: 24/02/2025

English (846.37 KB - PDF)View document

Study results

Study report

Feasibility of IVE studies in Nordic settings.pdf

English (1009.74 KB - PDF)View document

Influenza VE in Nordic countries-estimates for the 2024-2025 season.pdf

English (3.99 MB - PDF)View document

Other information

ENCePP Seal

ENCePP Seal documents

Secondary tabs